CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE647.6019.3 (+3.07 %)
PREV CLOSE (Rs.) 628.30
OPEN PRICE (Rs.) 635.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 781715
TODAY'S LOW / HIGH (Rs.)632.05 651.00
52 WK LOW / HIGH (Rs.)356.75 651
NSE648.1519.8 (+3.15 %)
PREV CLOSE( Rs. ) 628.35
OPEN PRICE (Rs.) 633.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 648.15 (846)
VOLUME 10580213
TODAY'S LOW / HIGH(Rs.) 631.00 650.95
52 WK LOW / HIGH (Rs.)355.3 650.95
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
5045.74
Dividend Yield(%)
0.46
TTM EPS (Rs.)
28.75
P/E Ratio
22.52
Book Value (Rs.)
215.85
Face Value (Rs.)
2
MCap (Rs. in Mn)
522120.53
Price/Earning (TTM)
17.89
Price/Sales (TTM)
4.27
Price/Book (MRQ)
3.00
PAT Margin (%)
14.48
ROCE (%)
16.69
Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000 / 022-24826951

Website : www.cipla.com

Registrars Details :

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
30May Cipla reports 33% fall in Q4 consolida
Cipla has reported results for the fourth quarter and year ended March 3..
21May Cipla, Tata Power and Natco Pharma to
Cipla has received final approval for its Abbreviated New Drug Applicati..
21May Cipla gets USFDA’s final approval for
Cipla has received final approval for its Abbreviated New Drug Applicati..
QTR Mar 20 ANNUAL 20
Net Profit6045.723181.7
Gross Profit 7085.5 29643.1
Operating Profit 8782.1 36001.4
Net Sales 31334.4 126591.5
Rs. in Millions
Dr. Reddys Lab (BSE)
 4073.80 (4.76%)
M.Cap (Rs. in Cr)67695.18
Abbott India (BSE)
 16728.05 (0.80%)
M.Cap (Rs. in Cr)35545.94
Astrazeneca Pharma I (BSE)
 3044.50 (4.52%)
M.Cap (Rs. in Cr)7611.25
Divis Lab (BSE)
 2395.75 (4.92%)
M.Cap (Rs. in Cr)63599.64
PROMOTERS
36.68%
NON-INSTITUTION
22.71%
MUTUAL FUNDS/UTI
16.93%
FI/BANKS/INSURANCE
5.54%
FII
0.01%
GOVERNMENT
0%
Attention Investors KYCIPO

REGISTERED OFFICE

5, Lower Rawdon Street, Akaashdeep 1 st Floor, Kolkata 700020,India.

Copyrights @ 2015 C AUM Capital Mkt. Pvt. Ltd. All Rights Reserved
Designed , Developed & Content Powered by   Accord Fintech Pvt. Ltd.

AUM Capital Market Pvt Ltd :SEBI Single Registration Number : INZ000185431 [ NSE : CM, FO, CD , BSE CM, FO , CD, MCX(COMMODITY), NSE & BSE COMMODITY, Registered Member Code: 12764 (NSE), 3180(BSE), 56505 (MCX). AMFI ARN. No. 64606 Depository Participant : NSDL : DP Id: IN304211, CDSL: SEBI Registration no. : IN-DP-CDSL-479-2008 DP Id: 12057800. Research Analyst SEBI Registration no.: INH300002423 CIN: U67120WB2005PTC103417
FOR ANY GRIEVANCE OR INVESTOR COMPLAINT, PLEASE MAIL US AT helpdesk@aumcap.com
Aum Capital Market Pvt. Ltd. is a distributor of Mutual Fund & IPOs.Investment in Securities is subject to market risk.

VISIT COUNT     100667

CLOSE X

Filling complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filling complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances